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Macrophages andmicroglia can be polarized along a
continuum toward a detrimental (M1) or a beneficial
(M2) state in the injured CNS. Although phagocytosis
of myelin in vitro promotes M2 polarization, macro-
phage/microglia in the injured spinal cord retain a
predominantly M1 state that is detrimental to recov-
ery. We have identified two factors that underlie this
skewing toward M1 polarization in the injured CNS.
We show that TNF prevents phagocytosis-mediated
conversion from M1 to M2 cells in vitro and in vivo
in spinal cord injury (SCI). Additionally, iron that
accumulates in macrophages in SCI increases TNF
expression and the appearance of a macrophage
population with a proinflammatory mixed M1/M2
phenotype. In addition, transplantation experiments
show that increased loading of M2 macrophages
with iron induces a rapid switch from M2 to M1
phenotype. The combined effect of this favors pre-
dominant and prolonged M1 macrophage polariza-
tion that is detrimental to recovery after SCI.
INTRODUCTION
Microglia, the yolk sac-derived resident immune cells in the
CNS, respond rapidly, within minutes, to injury (Davalos et al.,
2005). Although the early response of these cells is protective
(Hines et al., 2009), they rapidly become proinflammatory and
set off a cascade of responses that lead to the entry of periph-
eral immune cells, primarily those of the monocyte-macrophage
lineage (Kigerl et al., 2006). As microglia become activated they
retract their cytoplasmic processes and become indistinguish-
able by morphology and cell-surface markers from macro-
phages that enter the injured CNS via the peripheral circulation.
The macrophage response that is triggered by CNS injury
contributes to secondary damage and loss of function (David
and Kroner, 2011; David et al., 2012; Popovich and McTigue,
2009). On the other hand, macrophages can have protective and1098 Neuron 83, 1098–1116, September 3, 2014 ª2014 Elsevier Inc.regeneration-promoting effects in the injured CNS (Schwartz
and Yoles, 2005). This dual nature of macrophages is now
thought to be due to their polarization states. Macrophages
have heterogeneous phenotypes that range along a continuum
from the ‘‘classically-activated’’ proinflammatory, cytotoxic M1
cells to the ‘‘alternatively-activated’’ anti-inflammatory, prorepair
M2 cells (Gordon and Taylor, 2005; Martinez et al., 2008). Inter-
feron-g (IFN-g, the prototypic T helper 1 [Th1] cytokine) and the
Toll-like receptor-4 (TLR-4) ligand, lipopolysaccharide (LPS),
induce M1 polarization, while the Th2 cytokine IL-4 and other
factors induce M2 polarization (David and Kroner, 2011; Gordon
and Taylor, 2005).
An earlier study showed that although both M1 and M2 mac-
rophages are present in the injured spinal cord, the spinal cord
environment favors polarization of predominantly M1 cytotoxic
macrophages (Kigerl et al., 2009). Another recent study showed
that the M2 macrophages enter the injured spinal cord via the
central canal and are neuroprotective (Shechter et al., 2013).
Gaining an understanding of why the spinal cord environment
favors largely M1 polarization is important to developing ap-
proaches to reduce M1 and enhance protective M2 polarization
to promote recovery after injury. Previous work has shown that
myelin phagocytosis in vitro induces a shift in expression from
proinflammatory to anti-inflammatory cytokines (Boven et al.,
2006; Liu et al., 2006). Tissue damage and hemorrhage that re-
sults from spinal cord injury (SCI) leads to phagocytosis of
damaged myelin and red blood cells (RBCs), which are a rich
source of iron. How such phagocytosis influences macrophage
andmicroglia polarization is not clearly understood. In this paper,
we show that despite the fact thatmyelin phagocytosis in vitro in-
duces M1-polarized macrophages and microglia to switch to a
M2 state, macrophages/microglia in the injured spinal cord
remain predominantly M1 polarized even after the time when
they phagocytose myelin and apoptotic cells. We show that
TNF whose expression is regulated by MAP kinase-activated
protein kinase 2 (MK2) plays a crucial role in preventing M2 and
promoting M1 polarization. We also show that high intracellular
iron accumulation in macrophages induces TNF expression;
the appearance of a proinflammatorymixedM1/M2macrophage
population; and switching from M2 to M1 phenotype. These
mechanisms contribute to the prolonged maintenance of proin-
flammatory cytotoxicM1macrophages in the injured spinal cord.
Figure 1. M1 Markers Are Predominantly Expressed after SCI
Flow cytometry of macrophages/microglia extracted from the spinal cord of laminectomized mice (Lam) or mice at 1, 4, and 15 days after injury
(A) Representative dot blot of CD11b+, CD45+, macrophages/microglia. Gates show CD45high (macrophages) and CD45low cells (microglia).
(B and C) Representative plots at 4 days after SCI for macrophages (B) and microglia (C) showing labeling with primary antibody and isotype controls.
(D–I) Quantification of expression of M1: CD16/32 (D), CD86 (E), iNOS (F), or M2markers: arginase-1 (G), CD206 (H), and TGF-b (I) in macrophages andmicroglia.
Note that the percentage of cells expressing M1 markers (CD16/32 and CD86) is much higher than expression of M2 markers (arginase-1, CD206), indicating a
predominantly M1 polarization in the injured spinal cord. Cells were pooled from 3 mice per group for a total of 3 separate experiments for each time point.
Means ± SD; *, significant difference compared to laminectomy (*, p < 0.05; **, p% 0.01; ***, p% 0.001); #, compared to day 1(#, p < 0.05; ##, p% 0.01; ###,
p% 0.001); +, significant difference (p < 0.05) between macrophages and microglia.
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Macrophages in the Injured Spinal Cord Are Mainly
Polarized to a M1 Phenotype
Previous work using RT-PCR, a microarray analysis of select
genes and immunofluorescence staining, showed a predomi-
nance of M1 macrophage polarization in the injured mouse spi-
nal cord (Kigerl et al., 2009). We extended this work at the protein
and single-cell level using fluorescence-activated cell sorting
(FACS) analysis to assess the expression of a variety of M1
and M2 markers in macrophages and microglia in the adult
mouse spinal cord at 1, 4, and 15 days after contusion injury.NeThese time points were chosen to investigate the very early
microglia response before the influx of macrophages (1 day),
the early influx of macrophages from the peripheral circulation
(4 days), and the maximal phagocytic response of macro-
phage/microglia (15 days). This analysis revealed that much
higher percentages of macrophages (CD11b+, CD45high) andmi-
croglia (CD11b+, CD45low) expressM1markers (CD16/32, CD86)
than M2 markers (CD206, arginase-1 and TGF-b) (Figures 1D,
1E, and 1G–1I).
Macrophages show a steady increase in expression of the M1
marker CD16/32 between 1 and 15 days after SCI, reaching a
maximum of about 60% (Figure 1D). CD86, another M1 marker,uron 83, 1098–1116, September 3, 2014 ª2014 Elsevier Inc. 1099
(legend on next page)
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ing a maximum of about 20% at day 4 (Figure 1E). In contrast,
microglia show a steady level of expression of CD16/32 at about
30% for the entire 2 week period. CD86 was also expressed in
about 10%15% of microglia. These results indicate that the
expression of these M1 markers is more robust in macrophages
than in microglia, particularly at day 15. Interestingly, iNOS,
which shares the same substrate (L-arginine) with arginase-1,
is only expressed in a small proportion of macrophages and mi-
croglia (Figure 1F) andmay therefore not be a goodM1marker in
the context of SCI.
The M2 markers CD206, arginase-1, and TGF-b are only
expressed in a small percentage of cells (Figures 1G–1I). Argi-
nase-1 is expressed in about 8% of microglia at day 4 and
reduced to 3% at day 15 after injury, while only 2% of macro-
phages express arginase-1 throughout the 2 week period.
CD206 is expressed in about 2% of macrophages andmicroglia.
The level of expression of TGF-b, a M2 cytokine, is similar in mi-
croglia andmacrophages at day 4 (8%–10%) and reduced 2-fold
by day 15. These findings further indicate that M1 polarization is
favored in the injured spinal cord.
Myelin Phagocytosis In Vitro Induces Change in
Polarization from M1 to M2, Resulting in a Less
Cytotoxic Phenotype
Evidence that macrophages in the injured spinal cord have pre-
dominantly a M1 phenotype is surprising as phagocytosis of
apoptotic cells and myelin by activated macrophages leads to
downregulation of proinflammatory cytokines (Boven et al.,
2006; Voll et al., 1997). We therefore carried out experiments
to assess whether myelin phagocytosis by activated bone
marrow-derived macrophages (BMDMs) and microglia also
induce changes in expression of a panel of M1 and M2 markers
and importantly whether this alters their cytotoxic properties.
BMDMs and microglia were activated by the toll-like receptor-
4 (TLR-4) ligand, LPS, or a combination of LPS and IFN-g (i.e.,
M1 polarizing conditions) followed by myelin phagocytosis,
and the expression of M1 and M2 markers was assessed by
FACS analysis.
Effects of Phagocytosis on Expression of M1 and
M2 Markers
Effects on BMDMs. Myelin phagocytosis by LPS and LPS+IFN-
g-activated BMDMs resulted in a decrease in the proportion of
cells expressing M1 markers (CD16/32 and CD86) and increase
in cells expressing M2 markers (CD206 and CD204) (Figures 2B,
2C, 2E, and 2F) as compared to LPS and LPS+IFN-g. Similar re-
sults were seen with measurement of the relative fluorescence
units [RFU]) (see Figure S1 available online). We confirmed thatFigure 2. Phagocytosis of Myelin In Vitro Changes Polarization of BMD
Flow cytometry of BMDM (A–G) and microglia cultures (H–O) after stimulation w
(A and H) Representative dot blots of BMDMs (A) andmicroglia (H) showing a purit
32, CD86, TNF), M2 markers (CD206, CD204), the monocyte marker Ly6C, and
(B–G) BMDMs: Graphs (B–D) show that induction of M1 markers and Ly6C (G) by
myelin phagocytosis increases expression of M2 markers (E and F) following LP
(I–O) Microglia: Graphs (I–K, N) show that the increase in expression of M1 mar
phagocytosis (except for CD86 treatedwith LPS/IFN-g). Myelin phagocytosis also
LPS/IFN-g. Also see Figures S1–S3. Means ± SD, n = 3–4; *, p < 0.05; **, p% 0.
Nethese effects are due to phagocytosis by labeling myelin with a
pH sensitive dye (pHrodo Red, SE) that fluoresces when taken
up into lysosomes. Under these conditions cells that phagocy-
tosed myelin show decreased expression of M1 and increased
expression ofM2markers (Figure S2). Previous reports indicated
that TNF mRNA is reduced in macrophages after myelin phago-
cytosis in vitro (Boven et al., 2006). Our FACS analysis shows
that myelin phagocytosis almost completely blocks LPS and
LPS+IFN-g-induced increase in TNF protein expression (Fig-
ure 2D). Ly6C, which is highly expressed in LPS-activated
BMDMs, was also markedly reduced by myelin phagocytosis
(Figure 2G).
Effects on Microglia. Myelin phagocytosis by LPS-activated
microglia also resulted in reduction in M1 markers (CD16/32,
CD86, TNF, and iNOS) (Figures 2I–2K and 2N) and increased
expression of M2 markers (CD206 and arginase-1) as compared
to LPS and LPS+IFN-g activation (Figures 2L and 2M). CX3CR1
(fractalkine receptor), which contributes to proinflammatory
damage after SCI (Donnelly et al., 2011), is highly expressed in
microglia stimulated with LPS or LPS+IFN-g and is markedly
reduced after myelin phagocytosis (Figure 2O). Similar changes
are seen in the RFU values (see Figure S1).
These effects of phagocytosis onmacrophage polarization are
not entirely unique to myelin as it is also seen with phagocytosis
of apoptotic neutrophils and red-blood cells (RBCs) but with
important differences. Quantitative real-time PCR analysis of
mRNA expression of M1 markers after phagocytosis of myelin,
apoptotic neutrophils, or RBCs by LPS-activated BMDMs
showed that although phagocytosis of all three reduced expres-
sion of cell-surface M1markers (CD16, CD86) there were impor-
tant differences in proinflammatory cytokine expression. Unlike
myelin phagocytosis, which almost completely eliminates the
LPS-induced increase in TNF and IL-12 (90%–100% reduction),
phagocytosis of apoptotic neutrophils results in continued high
expression of IL-12 at the level induced by LPS, while after
RBC phagocytosis high TNF expression is maintained at the
LPS level and remarkably there is a 3.8-fold increase of IL-12
(see Figure S4). These results indicate that phagocytosis of
different targets has selective effects on polarization. Further-
more, phagocytosis of RBCs by unstimulated macrophages
also markedly upregulates expression of TNF and IL-12, unlike
phagocytosis of myelin or apoptotic neutrophils, which do not
alter the expression of these cytokines from the unstimulated
levels (see Figure S4).
Effects on Neuronal Survival and Neurite Growth
Functional effects of the strong M2 polarizing nature of myelin
phagocytosis on macrophages/microglia were assessed using
neuronal survival and outgrowth assays.Ms and Microglia from M1 to M2
ith LPS, LPS/IFN-g, or each followed by myelin phagocytosis.
y of > 90% and representative plots showing expression of M1markers (CD16/
isotype controls.
LPS or LPS/IFN-g is significantly reduced by myelin phagocytosis. In addition,
S or LPS/IFN-g stimulation.
kers and CX3CR1 (O) by LPS or LPS/IFN-g is significantly reduced by myelin
increases expression ofM2markers (L andM) following stimulation with LPS or
01; ***, p% 0.001.
uron 83, 1098–1116, September 3, 2014 ª2014 Elsevier Inc. 1101
Figure 3. Neurite Growth Effect of Macrophage-Conditioned Medium from LPS and LPS + Myelin-Treated BMDM Cultures
Incubation of mouse DRG neurons with conditioned medium from untreated BMDMs (control) or BMDMs treated with LPS (LPS) or LPS followed by myelin
phagocytosis (LPS-myelin).
(A–C) Representative images of neurons from cultures treated with (A) control medium, (B) LPS, and (C) LPS-myelin groups. Note the extensive neurite growth in
neuronal cultures treated with the conditioned medium from LPS-myelin.
(D) Sholl analysis of neurite growth shows a significant increase in the number of intersections (i.e., number of branches) and neurite length in DRGs incubated
with conditioned medium from the LPS-myelin group as compared to the LPS group.
(E and F) Incubation with medium from LPS-treated BMDMs significantly reduced neurite length (E) and branching complexity (F; which shows the area under the
curve shown in D) as compared to control medium. This reduction was rescued to control levels by incubation with conditioned medium from LPS-myelin-treated
BMDM cultures. Means ± SEM, n = 3; *, p < 0.05. Scale bar in (C), 500 mm.
(legend continued on next page)
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properties of LPS-activated BMDMs and microglia. Cerebral
cortical neuron cultures were treated for 5 days with conditioned
medium obtained from BMDMs or microglia cultures treated
with one of the following: (1) LPS, (2) LPS followed by myelin
phagocytosis, or (3) untreated cells (control); cytotoxicity was
measured by the lactate dehydrogenase (LDH) assay. Cell death
induced by culture medium from LPS-activated microglia (403 ±
73 mU/ml) was completely eliminated by myelin phagocytosis
and was similar to conditioned media from untreated cells (value
of 0 in both) (p value = 0.03). In the case of BMDMs, cell death
induced by LPS-activated culture medium (190 ± 40 mU/ml)
was reduced about 25% by myelin phagocytosis (144 ± 4 mU/
ml) (p value = 0.036), which is the same level as that of culture
medium from untreated BMDM cultures (148 ± 9 mU/ml), indi-
cating that myelin phagocytosis reverses the cytotoxic effects
induced by LPS activation.
Neurite Growth. To assess neurite outgrowth, dissociated
neonatal mouse dorsal root ganglion (DRG) neurons were
plated on laminin-coated glass coverslips in nerve growth fac-
tor-containing medium. After culturing overnight, DRG neurons
were treated for 24 hr with conditioned medium from control un-
treated BMDM cultures, BMDMs treated with LPS, or LPS fol-
lowed by myelin phagocytosis (Figures 3A–3C). Sholl analysis
revealed that LPS-treated BMDM supernatants reduced the
length of neurite growth, as well as the total number of neuritic
branches, as compared to supernatants of untreated controls
(Figures 3A–3F). Interestingly, incubation of DRG cultures with
conditioned medium of LPS-treated BMDMs that phagocytosed
myelin increased the length of neurite growth (Figure 3E) and the
total number of branches (Figure 3F), restoring it to the control
level. These data show that myelin phagocytosis by LPS-treated
BMDMs reverses the negative effects of M1-polarized BMDMs
on neurite growth.
Taken together, these results indicate that myelin phagocy-
tosis by M1-polarized macrophages and microglia induces a
change to M2 polarization. Importantly, the functional conse-
quence of this is the reversal of LPS-induced cytotoxic proper-
ties of macrophages on neuronal viability and neurite growth.
Myelin Phagocytosis Inhibits NF-kBSignaling. BMDMs treated
with LPS show a marked increase in translocation of the p65
subunit of NF-kB from the cytosol (in unstimulated condition)
to the nucleus (Figures 3G–3I). This LPS-induced nuclear trans-
location of p65 was strongly suppressed bymyelin phagocytosis
similar to the level seen with the IkBa inhibitor (BAY11-7082).
These results were further confirmed by western blot analysis
of IkBa of LPS-treated BMDMs with and without myelin phago-
cytosis. These experiments showed a 2-fold increase in total
IkBa after myelin phagocytosis by LPS-treated cells as
compared to cells treated with LPS alone, indicating that IkBa
degradation, a sign of activation of the NFkB pathway (Baeuerle(G–I) Quantification shows increased nuclear translocation of the p65 subunit of N
(G). This LPS-induced increase is reduced to unstimulated levels by myelin pha
Representative image showing LPS-induced nuclear localization of p65 (cyan co
cultures treated with LPS and myelin (I). Nuclei labeled with DAPI (blue). n = 3/gr
(J and K) Quantification of western blot data showing that myelin phagocytosis in
n = 4), which is further illustrated in a representative western blot (K).
Neand Baltimore, 1988), is inhibited in LPS-myelin-treated cells
(Figures 3J and 3K). These results suggest that the effects of
myelin phagocytosis on polarization are mediated in part via
the NF-kB pathway.
TNFContributes to the Persistence ofM1Polarization in
the Injured Spinal Cord
Despite the fact that macrophages and microglia phagocytose
myelin and other tissue debris in the first 2 weeks after spinal
cord contusion injury, the environment of the injured spinal
cord favors M1 polarization as shown by our FACS analysis
described above (Figure 1), as well as in an earlier report (Kigerl
et al., 2009). Our search for potential candidates that can influ-
ence M1 polarization focused on TNF as TNF mRNA is rapidly
upregulated after contusion injury in mice and is expressed by
microglia and other CNS cell types (Pineau and Lacroix, 2007).
Our FACS analysis shows that expression of TNF at the protein
level is also increased rapidly in macrophages and microglia
after SCI and continues to be expressed by macrophages at
15 days postinjury (Figure 4A).
We therefore assessed whether TNF can influence M1 polari-
zation of macrophages and microglia in our in vitro model.
Incubation of LPS-stimulated BMDMs andmicroglia with recom-
binant TNF (rTNF) completely prevented the myelin phagocy-
tosis-induced reduction in the M1 marker CD16/32 as detected
by FACS analysis (Figures 4B and 4C). Furthermore, quantitative
real-time PCR (qPCR) analysis showed that addition of rTNF to
LPS andmyelin-treated BMDMs also led to a significant increase
of other M1 markers (fold increase of CD86 = 2.6 ± 1.1; iNOS =
12.1 ± 1.9; IL-12 = 106.7 ± 86.4; TNF = 4.5 ± 1.9) and reduction
of the M2 marker expression (fold reduction of CD206 = 12.1 ±
2.07). Recombinant TNF treatment, however, does not block
myelin phagocytosis (see Figure S5). In addition, LPS-treated
BMDMs from TNF null mice showed decreased expression of
M1 polarization markers (CD86, iNOS and IL-12), which were
further reduced by myelin phagocytosis (Figure S5). These
data indicate a TNF-dependent and TNF-independent effect
on the myelin effect on M1 polarization. Furthermore, the reduc-
tion in neurite growth from DRG neurons induced by superna-
tants from LPS-treated BMDMs was completely abrogated
when BMDMs from TNF null mice were used (see Figure S5).
These data indicate that TNF can prevent the myelin phagocy-
tosis-induced switch from M1 to M2 and thus retain the cells in
a proinflammatory M1 state and also mediate the neurite growth
inhibitory effects of LPS-activated M1 macrophages.
We next assessed the role of TNF onmacrophage polarization
and recovery after SCI. Double immunofluorescence labeling of
tissue sections of wild-type and TNF null mice 7 days after contu-
sion injury showed a shift in macrophage polarization toward M2
cells with a 2-fold increase in expression of the M2markers argi-
nase-1 (Figures 4D–4F) and CD206 (Figures 4G–4I) and a smallFkB in BMDM cultures treated with LPS as compared to unstimulated cultures
gocytosis. A similar effect is also seen with the IkBa inhibitor (BAY11-7082).
lor) (H) as compared to the predominantly cytoplasmic localization (green) in
oup. Scale bar in (I), 20 mm.
creases total IkBa levels as compared to LPS-treated BMDMs (J, * = p > 0.5,
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Figure 4. TNF Contributes to M1 Polarization In Vitro and in the Injured Spinal Cord
(A) Flow cytometry analysis of TNF expression in macrophages/microglia obtained from the spinal cords of laminectomized mice (Lam), and at 1, 4, and 15 days
after contusion injury. Note the increased expression of TNF in microglia and macrophages after injury. Means ± SD; *, significant difference compared to
laminectomy. *, p% 0.01; #, p < 0.05 compared to day 1; +, p < 0.05 between macrophages and microglia.
(B and C) Treatment of BMDMs (B) and microglial (C) cultures with rTNF completely prevents myelin phagocytosis-induced reduction of the M1 marker CD16/32
in LPS-treated cultures. Means ± SD; n = 3–4.
(legend continued on next page)
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Figure 5. MK2 Contributes to M1 Polariza-
tion after SCI
Confocal images showing spinal cord of wild-type
(A, D, and G) andMK2/ (B, E, and H) mice 7 days
after contusion injury. Micrographs show full z
stack images (14 mm) and the x–y, x–z, and y–z
planes of double labeling for arginase-1 (A and B),
CD206 (D and E), and CD86 (G and H), each
double labeled with a macrophages marker
(CD11b or Iba-1) and DAPI labeling for nuclei.
Arrows indicate examples of double-labeled cells.
(C, F, and I) Quantification of the percentage of
macrophages/microglia expressing arginase-1,
CD206, and CD86. Note thatMK2/ mice have a
significantly higher percentage of macrophages/
microglia expressing M2 markers and a lower
percentage of cells expressing the M1 marker
CD86 as compared to wild-type mice. (n = 3/
group). Scale bar, 40 mm. Means ± SEM. *,
p < 0.05.
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wild-type mice versus 56.3 ± 3.6 in TFN-a null mice; p value =
0.01). These results show that the expression of TNF in the
injured spinal cord contributes to promoting M1 polarization.
We also found that TNF null mice showed a remarkable improve-
ment in locomotor recovery based on the 9-point Basso Mouse
Scale (BMS) analysis. This is in agreement with studies showing
that treatment with TNF antagonists improves recovery after SCI
(Chen et al., 2011; Genovese et al., 2006). Our results show that
the BMS scores were improved by about 3 points. By 28 days
after SCI the wild-type mice had a BMS score of 3 while the
TNF null mice had improved to a score of 6. A score of 3 means
that the wild-type mice showed no plantar stepping, while a
score of 6 indicates that the TNF/ mice showed frequent or
consistent plantar stepping with coordination (Figure 4J). In
addition, striking improvement was seen in the BMS subscores
that evaluate finer aspects of locomotor control. The BMS sub-
score improved from an average score of 0.8 in the wild-type
to 5.3 in TNF null mice at day 28 (Figure 4K).(D–I) TNF/ mice show a significantly higher percentage of macrophages expressing M2 markers arginase-1
after contusion injury. Confocal full z stack images (14 mm) and the x–y, x–z, and y–z planes showing double la
Arrows indicate examples of double-labeled cells. Scale bar, 40 mm; n = 3–6.
(J and K) Time course of locomotor recovery in TNF/ and wild-type controls. Evaluation was done using
11-point BMS subscore (K). Note that TNF/ mice recover significantly better compared to wild-type
Means ± SEM. *, p < 0.05; **, p% 0.01; ***, p% 0.001
Neuron 83, 1098–1116, SeMK2 Drives TNF-Induced M1
Polarization after SCI
We have previously reported that TNF
expression in the injured spinal cord is
reduced about 26-fold in MK2 null mice
as compared to wild-typemice (Ghasem-
lou et al., 2010). We therefore assessed
the expression of M1 and M2 markers in
CD11b+ macrophages/microglia in the
spinal cord of MK2 null mice 7 days
after contusion injury. There was a 2-
fold increase in arginase-1 expression(increasing it to about half of all CD11b+ cells) (Figures 5A–5C)
and a 3-fold increase in CD206 (Figures 5D–5F) in MK2 null
mice as compared to wild-type controls. There was also a signif-
icant reduction in the M1 marker CD86 (Figures 5G–5I). The in-
creases in the M2 markers arginase-1 and CD206 were compa-
rable to those seen in TNF null mice (Figures 4F and 4I). These
results indicate that the remarkable improvement in locomotor
recovery after SCI in MK2 null mice, which we reported earlier
(Ghasemlou et al., 2010), is probably mediated by reduction in
TNF which results in a predominance of protective M2 macro-
phage polarization.
Increased Intracellular Iron Influences TNF Expression
and Macrophage Polarization
Spinal cord contusion injury results in hemorrhage and extrava-
sation of red blood cells (RBCs) into the spinal cord, which are
rapidly phagocytosed by macrophages. Iron is also likely to be
released from dying cells and taken up by macrophages. Ferritin
is an iron binding and storage protein, the expression of which is(D–F) and CD206 (G–I) than wild-type mice 7 days
beling plus DAPI labeling for nuclei (D, E, G, and H).
the 9-point Basso Mouse Scale (BMS) (J) and the
controls. (n = 7–9 mice/group). See Figure S5.
ptember 3, 2014 ª2014 Elsevier Inc. 1105
Figure 6. Iron Accumulation Influences TNF Expression and Macrophage Polarization in the Injured Spinal Cord
(A) Single-plain confocal images of triple immunofluorescence showing labeling of macrophages/microglia with CD11b, ferritin, and TNF in spinal cord injury
tissue of C57BL/6 mice at 7 days after injury and a full z stack image (merge) (14 mm) showing the triple labeling in the x–y, x–z, and y–z planes. Arrows indicate
triple-labeled cells.
(B) Quantification shows significantly higher percentage of TNF expression in ferritin+ (Fe+) than in ferritin-negative (Fe) macrophages/microglia in SCI tissue,
7 and 14 days after injury.
(C–E) Confocal images of wild-type injured spinal cord 7 days after injury showing full z stack images (14 mm) and the x–y, x–z, and y–z planes of triple labeling for
CD11b and ferritin combined with either arginase-1 (C), CD206 (D), or CD16/32 (E).
(legend continued on next page)
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surrogate marker for intracellular iron. We examined the expres-
sion of TNF in ferritin+, CD11b+ macrophage/microglia in wild-
type mice at 7 and 14 days after SCI. Interestingly, the number
of ferritin+ macrophages/microglia that expressed TNF was 2-
to 3-fold greater than in ferritin-negative CD11b+ cells (Figures
6A and 6B), with the majority (60%–80%) of the ferritin+ cells ex-
pressing TNF. In the absence of TNF (i.e., in TNF null mice) there
is a 2.4-fold increase in the expression of the M2 marker CD206,
a 60% increase in arginase-1, and a significant decrease (22%)
in the M1 marker CD16/32 in iron-containing CD11b+ macro-
phage/microglia as compared to wild-type mice (Figures 6C–
6I). Similar increases in the expression of arginase-1 and
CD206 and decrease in CD16/32 in ferritin+ macrophages
were also detected in the injured spinal cord of MK2 null mice
(Figure 6J). Since TNF and CD16/32 are expressed in close to
80% of the ferritin-containing cells in wild-type mice (Figures
6B and 6F), the expression of arginase-1 in about 40% of the
ferritin-containing macrophages suggests the presence of a
subpopulation with a mixed M1/M2 phenotype that is proinflam-
matory. Figure 6K shows evidence of ferritin+ cells expressing
M1 (CD16/32) and M2 (arginase-1) markers in the same cell
(also see Figure S6). Cells coexpressing other M1/M2 markers,
i.e., iNOS/arginase, were also detected by FACS analysis
between 1 and 15 days after SCI (data not shown). A similar pop-
ulation of iron-containing macrophages with mixed M1/M2
proinflammatory phenotype was also found in chronic skin ul-
cers, in which they cause tissue damage (Sindrilaru et al.,
2011). These data suggest that TNF increasesM1 and decreases
M2 polarization particularly in iron-containing macrophages in
the injured spinal cord.
Iron Levels Influence TNF Expression and Functional
Outcome In Vivo after SCI
After SCI,manymacrophages are already iron loaded because of
the phagocytosis of RBCs that enter the tissue due to hemor-
rhage. We tested whether increasing the iron load further by sys-
temic treatment with iron-dextran would alter TNF expression
and worsen outcome after SCI. Mice were treated daily for
7daysafter injurywith 5mgof iron-dextran intraperitoneally start-
ing 1day prior to contusion injury. Strikingly, a 3.5-fold increase in
TNF expression was detected by ELISA in the injured spinal cord
of mice treated with iron-dextran as compared to control(G–I) Similar staining of spinal cord injured tissue from TNF/ mice 7 days after
(F) Shows quantification of the percentage of triple-labeled cells. Note the incre
expressM2markers (arginase-1 andCD206) and reduction in the percentage of ce
(J) MK2/ mice show significantly greater percentage of ferritin+, CD11b+ mac
marker CD16/32 as compared to wild-type mice. n = 3–6 mice/group.
(K) Merged confocal single-plane image showing ferritin+ cells (macrophages) tha
more details). Scale bar, 10 mm.
(L and M) Representative micrographs showing DAB-enhanced Turnbull’s blue
dextran (M)-treated mice at 28 days postinjury. Note the strong and widespread
(N) Iron-dextran treatment induces a significant increase in TNF expression in sp
(O) BMS analysis showing that iron treatment for 7 days after SCI results in signific
treated controls (n = 5–6 mice/group).
(P–R) Locomotor performance at 28 days postinjury was analyzed using the Dig
significantly decreased, and stride frequency (R) was significantly increased in ir
iron-dextran-treated mice. See Figures S6 and S7. Mean ± SEM. *, p < 0.05; **,
Ne(dextran-treated)mice at 5dayspost injury (Figure 6N). Increased
iron deposition was seen in the injured spinal cord of iron-
dextran-treated mice as compared to dextran-treated control
mice detected by iron histochemistry (Figures 6L and 6M) as
well as using the ferrozine colorimetric assay (see Figure S7).
Mice treated with iron for 7 days and allowed to survive for
28 days showed increased transferrin saturation (see Figure S7).
Hematocrit andwhite blood cell counts in these iron-treatedmice
were in the normal range (see Figure S7). The systemic iron treat-
ment of mice with SCI worsened locomotor recovery compared
to vehicle-treated SCI controls despite the already high level of
iron from RBCs due to hemorrhage. BMS analysis showed that
locomotor recovery inmice treatedwith iron for 7 dayswasworse
than controls up to day 14 and then improved thereafter, which
may be due to gradual clearance of iron after stopping the iron
treatment at day 7 (Figure 6O). At day 14, 40% of the mice in
the control group were stepping, while none in the iron-treated
group were able to step. Differences were also detected in
various measures of the DigiGait analysis and include decreased
stride length and propulsion duration and increased stride fre-
quency (Figures 6P–6R), all indicative of poor recovery in the
iron-dextran-treated mice as compared to vehicle-treated con-
trols at 28 days after SCI. Functional consequences of iron treat-
ment at the cellular level within the spinal cord were observed
3 days after SCI as iron-treated mice showed increased genera-
tion of reactive oxygen species (ROS) detected using dihydroe-
thidium (DHE) oxidation as a marker (Figure 7A) and increased
apoptosis detected with the TUNEL stain (Figure 7B) as
compared to vehicle-treated SCI controls.
Iron Loading of M2 Macrophages Increases Switch to
M1 Polarization after Transplantation into the Injured
Spinal Cord
Previous work reported that BMDMs polarized in vitro by IL-4 to
aM2 phenotype fail to retain their M2markers when transplanted
into the injured spinal cord (Kigerl et al., 2009). We tested the
effects of iron loading on the polarization of such M2 cells after
transplantation into the injured spinal cord. BMDMs from GFP-
expressing mice were polarized to M2 cells by IL-4 and loaded
with either iron-dextran (nonheme iron) or RBCs (heme iron).
These cells were transplanted into the spinal cord 7 days after
contusion injury. The expression of M1 and M2 markers in
the transplanted GFP+ cells was assessed 3 days later byinjury.
ase in the percentage of ferritin+, CD11b+ macrophages in TNF/ mice that
lls expressing theM1marker (CD16/32). n = 3–5mice/group. Scale bar, 40 mm.
rophages expressing M2 markers and reduced numbers expressing the M1
t have amixed M1 (CD16/32) and M2 (arginase-1) phenotype (see Figure S6 for
staining at the epicenter of the injury in vehicle control (dextran) (L) and iron-
staining for iron in mice treated with iron-dextran (M). Scale bar, 500 mm.
inal cord tissue detected by ELISA at 5 days postinjury (n = 4 mice/group).
antly worse locomotor recovery during the first 14 days as compared to vehicle-
iGait system. Hind limb stride length (P) and duration of propulsion (Q) were
on-dextran-treated mice as compared to controls, indicating poor recovery in
p% 0.01.
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Figure 7. Systemic Iron Treatment In-
creases ROS Generation and Apoptosis in
the Injured Spinal Cord
(A–E) Dihydroethidium (DHE) oxidation by ROS
leads to nuclear localization of oxidized DHE
(ethidium) fluorescence labeling in the injured
spinal cord. Quantification of the nuclear staining
in cross-sections of the spinal cord shows
increased ROS generation in iron-treated SCI
mice as compared to vehicle-treated controls;
*p = 0.048 (A).
Representative confocal z stack images (14 mm)
show nuclear localization of oxidized DHE (red) in
DAPI-stained nuclei (blue) in control vehicle-
treated animals (B), and iron-dextran-treated ani-
mals (C), and at higher magnifications (D) (control)
and (E) (iron-treated). Arrows indicate examples of
nuclear localization; Student’s t test; n = 3–5.
Scale bars, 50 mm in (C) and 20 mm in (E).
(F–J) TUNEL staining of apoptotic cells. Graph
shows increased apoptosis in the injured spinal
cord of mice treated with iron as compared to
vehicle-treated controls; (*p = 0.036) (F). Repre-
sentative images showing TUNEL staining in
control SCI (G and I) and iron-treated (H and J) SCI
mice. Black squares in (G) and (H) indicate regions
shown at higher magnification in (I) and (J). Arrows
indicate examples of TUNEL-stained cells; Stu-
dent’s t test; n = 3–5. Scale bars, 500 mm in (H) and
20 mm in (J).
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dextran and RBC loading of M2-polarized BMDMs showed
marked reduction of the M2 marker CD206, which was 5-fold
less in RBC-loaded cells as compared to IL-4-treated cells (Fig-
ures 8A–8D). In addition, there was a significant increase in the
M1 marker CD16/32, as well as a 2.5-fold increase in TNF in
iron-dextran and RBC-loaded cells as compared to cells treated
with only IL-4 (Figures 8E–8L), indicating that iron loading in-
duces M2-polarized cells to switch to a proinflammatory M1
phenotype. qPCR analysis of cultured IL-4-treated BMDMs
loaded with iron-dextran overnight did not show an increase in
any of the M1 markers examined (CD16, CD86, iNOS, TNF) but
a 50% reduction in CD206 (Figure 8M). In striking contrast, IL-
4-treated BMDMs loaded with RBCs overnight showed marked
increase in all the M1 markers examined (CD16, CD86, iNOS,
TNF) and a marked reduction in M2 markers (CD206 and Ym-
1) (Figure 8M). When iron- and RBC-loaded BMDMs were left
in culture for 3 days in order to match the time the transplanted
cells were left in vivo, the expression of M1markers decreased in1108 Neuron 83, 1098–1116, September 3, 2014 ª2014 Elsevier Inc.the RBC-loaded cells and was un-
changed in iron-dextran-loaded cells
compared to the overnight cultures (Fig-
ure 8M). These results suggest that fac-
tors in the CNS environment also
contribute to the shift from M2 to M1
and the maintenance of this shift in
polarization.
Interestingly, when IL-4-treated
BMDMs from TNF null mice were loadedwith RBCs, it resulted in a 56% reduction of CD86 and about a
4.3-fold reduction in iNOS and a 2.7-fold reduction in IL-12 (all
M1 markers); and a 3-fold increase in the M2 marker CD206 as
compared to IL-4-treated BMDMs from wild-type mice (see Fig-
ure S8). These findings suggest that TNF plays an important role
in RBC phagocytosis-induced shift from M2 to M1 polarization.
Cytokine Gene Expression Profiling
We also carried out a broad cytokine and chemokine gene
expression profiling of IL-4-treated BMDMs loaded with iron-
dextran or RBCs, using a PCR array for 84 cytokines, chemo-
kines, and related genes. As may have been predicted based
on the qPCR results described above, IL-4-treated BMDMs
loaded with iron-dextran showed minimal changes in cytokine
expression as compared to cells loaded with RBCs. Iron-dextran
loading of M2 macrophages showed changes in only three
cytokines/chemokines: a 5-fold increase in MIP-2b/CXCL3/
GRO-gamma, a chemokine that is induced by proinflammatory
cytokines and is a potent neutrophil chemoattractant; a
Figure 8. Iron Loading Increases Shift from M2 to M1 Polarization In Vitro and after Transplantation into the Spinal Cord
GFP+ BMDMs were polarized in vitro with IL-4 and left either untreated or loaded with iron-dextran or senescent RBCs and then microinjected into the injured
spinal cord (7 days after injury). The percentage of GFP+ cells expressing CD206 was lower in iron-dextran and RBC-treated cells (A–D), while the expression of
CD16/32 (E–H) and TNF (I–L) was increased. Confocal images show full z stack images (14 mm) and the x–y, x–z, and y–z planes. Scale bar, 40 mm. CD16/32, TNF,
and GFP were visualized in the same sections (E–G, I–K) by triple labeling. Arrows indicate examples of colocalization of GFP with M1 and M2 markers. n = 3–6.
(M) qPCR data showing fold change in mRNA expression of M1 (CD16, CD86, iNOS, TNF) and M2 (CD206, Ym1) markers in BMDMs polarized with IL-4 and
loadedwith iron-dextran or RBCs for 16 hr or cultured for 3 days. Note the significant increase ofM1marker and decrease ofM2marker expression in cells loaded
with RBCs after 16 hr in culture. In contrast, the iron-dextran-loaded cultures at 16 hr show only a 50% reduction of CD206 but no change in any of the M1
markers. After 3 days in culture, the RBC-loaded cultures showed almost a complete loss of M1 and a partial reversal of the decrease of M2marker expression. In
contrast, iron-dextran-treated cultures after 3 days did not show any change in M1 marker expression but a reversal of CD206 and a decrease in Ym-1
expression. n = 3–4 per group. See Figure S8. Mean ± SEM. *, p < 0.05; **, p% 0.01; ***, p% 0.001.
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Table 1. Changes in Chemokine/Cytokine Expression inM2BMDMs (IL-4-polarized) Loadedwith RBCs as Compared to IL-4-Polarized
Cells
Gene Symbol Gene Title Fold Change Function p Value Reference
Proinflammatory
Il12b IL-12b 82482 M1 cytokine 0.03 (Bastos et al., 2002)
1l1b IL-1b 14230 M1 cytokine 0.04 (Sica et al., 2012)
Cxcl10 CXCL10 11191 M1 chemokine 0.02 (David and Kroner, 2011)
Ccl5 CCL5 5470 M1 chemokine 0.001 (Martinez et al., 2006)
Ifng IFN-g 274 M1 inducing cytokine 0.001 (Martinez et al., 2006)
Lta Lymphotoxin-a 265 Th1 cytokine 0.003 (Sica et al., 2008)
Tnf TNF 252 M1 cytokine 0.02 (Martinez et al., 2006)
Cd70 CD70 138 M1 cytokine* 0.02 (Martinez et al., 2006)
Tnfsf10 TRAIL 131 M1 cytokine* 0.02 (Martinez et al., 2006)
Ccl3 CCL3 74 M1 chemokine 0.02 (Mantovani et al., 2004)
Ccl2 CCL2 59 M1 chemokine 0.03 (Mantovani et al., 2004)
Csf2 GM-CSF 36 M1 inducer 0.004 (Martinez et al., 2006)
Cxcl16 CXCL16 30 M1 chemokine* 0.0001 (Mantovani et al., 2004)
Il15 IL-15 16 M1 cytokine* 0.01 (Martinez et al., 2006)
Ccl19 CCL19 15 M1 chemokine* 0.04 (Mantovani et al., 2004)
Il18 IL-18 13 M1 cytokine 0.04 (Bellora et al., 2010)
Ltb Lymphotoxin b 7 TNFsf, NFkB inducer 0.03 (Mackay et al., 1998)
Hc C5 6 proinflammatory 0.02 (Huber-Lang et al., 2006)
B2m b 2 microglobulin 6 Upregulated inM1 cells 0.01 (Corna et al., 2010)
Il17f IL17F 5 Inducible by LPS 0.01 (Bosmann et al., 2011)
Hsp90ab1 HSP90ab1 5 proinflammatory 0.003 (Qin et al., 2011)
Tnfsf13b TNF sf13b 4 M1 cytokine* 0.0001 (Martinez et al., 2006)
Mif MIF 4 M1 inducer 0.0001 (Mitchell et al., 2002;
Yaddanapudi et al., 2013)
Spp1 Osteopontin 2 Th1 cytokine 0.02 (Chabas et al., 2001)
Anti-inflammatory
IL1rn IL1ra 309 M2 cytokine 0.02 (Mantovani et al., 2004)
Ccl12 CCL12 216 M2 cytokine 0.03 (Murray and Wynn, 2011)
Lif LIF 137 M2/TAM inducer 0.01 (Duluc et al., 2007)
Ccl17 CCL17 32 M2a chemokine 0.001 (David and Kroner, 2011;
Martinez et al., 2006)
Csf1 M-CSF 17 M2 inducer 0.003 (Martinez et al., 2006)
Il13 IL13 4 M2a cytokine 0.03 (David and Kroner, 2011)
Adipoq Adiponectin 40 M2 inducer 0.02 (Lovren et al., 2010)
Ccl24 CCL24 8 M2 chemokine 0.04 (Mantovani et al., 2004)
Il16 IL-16 3 M2 inducer 0.004 (Gorvel et al., 2010)
Mixed
Csf3 G-CSF 750 pro-and anti-inflammatory 0.04 (Campbell et al., 2000; Martins
et al., 2010)
Il27 IL-27 193 produced in M1,
anti-inflammatory
0.01 (Liu et al., 2007; Owaki et al., 2006)
Osm Oncostatin M 21 produced in M1, M2 inducer 0.005 (Bruce et al., 1992; Guihard et al.,
2012; Komori et al., 2013)
Ifna2 IFN-a2 8 Mixed (elevated in SLE) 0.03 (Santer et al., 2009)
Ppbp CXCL7 5 Absence increases bacterial load.
Reduced in both M1 and M2
0.005 (Martinez et al., 2006)
(Continued on next page)
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Table 1. Continued
Gene Symbol Gene Title Fold Change Function p Value Reference
Il21 IL-21 4 Proinflammatory M2 inducer 0.04 (Pelletier et al., 2004;
Sarra et al., 2010)
Pf4 CXCL4 3 Mixed phenotype 0.03 (Gleissner, 2012;
Gleissner et al., 2010)
Vegfa VEGF A 3 Mixed phenotype with M1
dominance
0.01 (Linde et al., 2012)
*Upregulated in M1 cells, not typical markers.
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TNF and Iron Regulate M1 Polarization in SCI2.1-fold reduction in IL-1b; and a 3.4-fold reduction in BMP2,
which is involved in cytokine signaling and is reduced by proin-
flammatory cytokines such as TNF (Champagne et al., 2002).
In striking contrast to the iron-dextran-loaded cells, RBC-
loaded IL-4-treated BMDMs showed changes in 41 out of the
84 genes screened. Of these, increased expression was seen
in 25 M1 or M1-related cytokines and in another seven cytokines
with proinflammatory properties. The cytokine with the highest
upregulation was IL-12b, which is known to increase expression
of TNF and IL-1b, the latter of which (IL-1b) is the 2nd highest
cytokine upregulated (Table 1). The 5th–7th highest upregulated
cytokines are IFN-g (274-fold), TNF (252-fold), and lympho-
toxin-a (LTa) (265-fold). Other cytokines of note includeGM-CSF
(36-fold increase), which is involved in increasing macrophage
numbers in response to inflammation and, importantly, primes
macrophages to respond to LPS challenge by increasing
expression of TNF and IFN-g (Hamilton, 2002; Wing et al.,
1989); IL-18 (13-fold increase), which also induces expression
of IFN-g; and MIF (4-fold increase), which can suppress anti-in-
flammatory effects of glucocorticoids (Flaster et al., 2007) and
could therefore suppress M2 polarization. Only six cytokines
with anti-inflammatory properties were upregulated. The highest
upregulated in this group was IL-1 receptor antagonist (IL-1ra;
309-fold), which is probably increased in response to themarked
increase in IL-1b expression. Interestingly, only three cytokines
were downregulated, all of which are M2 cytokines (IL-16,
CCL24, and adiponectin). This gene array screening provides
strong evidence that loading M2-polarized BMDMs with RBCs
induces robust expression of a large panel of cytokines that favor
M1 polarization.
DISCUSSION
Macrophages and microglia are recognized as important
effector cells at the site of SCI. They mediate secondary dam-
age by the release of proinflammatory cytokines, proteases,
free radicals, and other factors (Popovich and Longbrake,
2008). However, under certain experimental conditions, acti-
vated macrophages can be beneficial and have prorepair and
regenerative properties in the injured CNS (Schwartz and Yoles,
2006). Macrophages play an essential role to protect the body
from pathogens, and after injury they clear dead and dying cells
and restore tissue homeostasis. Therefore, the macrophage/mi-
croglial response after spinal cord and other CNS injuries needs
to be modulated and steered in the direction of protection and
repair rather than being depleted or their actions blockedNecompletely. The diversity in the macrophage response is now
thought to be due in large part to their polarization state, which
is controlled by cytokines and other factors in the tissue envi-
ronment. This opens up possibilities to control the polarization
state of macrophages/microglia to favor repair after CNS injury
or disease.
We have presented evidence that along with data reported
earlier (Kigerl et al., 2009) shows that macrophages/microglia
in the injured spinal cord are predominantly polarized to a M1
proinflammatory, cytotoxic cell type. Although M2macrophages
are present, their numbers are markedly reduced 7 days after
SCI (Kigerl et al., 2009). A recent study reported that some M2
macrophages reach the site of spinal cord injury via the choroid
plexus and move along the central canal down to the injury site
(Shechter et al., 2013). Blocking the entry of these cells along
this routeworsened locomotor recovery, indicating thatM2mac-
rophages contribute to the small residual locomotor function
remaining after contusion injury (Shechter et al., 2013). The pre-
dominant M1 response in the injured spinal cord suggests that it
contributes substantially to tissue damage and functional loss.
Macrophages are distributed throughout the cross-section of
the contused spinal cord during first 7–10 days after injury; later,
many of the iron-containing macrophages migrate to the center
of the cord (Kigerl et al., 2006; Rathore et al., 2008). The predom-
inance of M1 polarization was surprising as phagocytosis of
cellular debris including myelin is known to induce reduction of
proinflammatory and increase in anti-inflammatory cytokines
(Boven et al., 2006; Voll et al., 1997). In addition, we show that
myelin phagocytosis in vitro also induces M1-polarized macro-
phages and microglia to switch to an M2 state based on the
expression of several cell-surface and intracellular markers.
Myelin phagocytosis also abrogated the cytotoxic and neurite
growth-inhibiting effects of M1 macrophages polarized by LPS.
We also show that these myelin-induced effects appear to be
mediated via activation of the NF-kB pathway. In addition, there
is also evidence that myelin phagocytosis-induced reduction
of nitric oxide is mediated via PPARb/d (Bogie et al., 2013).
Previous work has shown that phagocytosis of apoptotic cells
induces alternate M2 polarization of macrophages (Gordon,
2003). Interestingly, our data show that phagocytosis of
apoptotic neutrophils and RBC also induced a shift in expres-
sion of cell-surface polarization markers from M1 to M2. How-
ever, unlike myelin, RBC phagocytosis by M1 macrophages
promotes strong proinflammatory cytokine expression, while
macrophages phagocytosing neutrophils still maintain IL-12
expression at the LPS levels. This suggests specificity in theuron 83, 1098–1116, September 3, 2014 ª2014 Elsevier Inc. 1111
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to note because in addition to myelin clearance, phagocytosis
of neutrophils and RBCs also occurs during the first 2 weeks
after spinal cord contusion injury.
The in vitro evidence that phagocytosis of myelin induces a
shift in macrophage polarization from M1 to M2 cells is at odds
with the predominance of M1 polarization in vivo in the injured
spinal cord, as phagocytosis of myelin and dying cells occurs
in the first 2 weeks after injury. This suggests that factors in the
injured CNS environment prevent the normal phagocytosis
induced shift in polarization to M2 cells that can lead to the res-
olution of inflammation. Our search for such factors focused on
TNF because the mRNA for this proinflammatory cytokine is
increased after SCI, is expressed in microglia, astrocytes, oligo-
dendrocytes and neurons (Pineau and Lacroix, 2007), and is a
potent driver of inflammation in a wide variety of conditions.
Our FACS data show that it is rapidly expressed at the protein
level in macrophages and microglia and continues to be ex-
pressed bymacrophages at 15 days after SCI. TNF can therefore
act via both paracrine and autocrine mechanisms to influence
macrophage/microglia responses. Importantly, we found that
rTNF eliminated the myelin-induced switch in polarization of
LPS-treated BMDMs from M1 to M2 in vitro. In addition, there
is a greater shift from M1 to M2 polarization in LPS-treated
BMDMs from TNF null mice that have phagocytosed myelin.
We also obtained two lines of evidence that strongly support
the in vivo role of TNF in maintaining M1 polarization in SCI
despite phagocytosis occurring in the tissue: (1) functional loss
after SCI is less severe in TNF null mice and, more importantly,
the absence of TNF results in a marked increase in M2 macro-
phage/microglia in the injured spinal cord; and (2) a similar in-
crease in M2 macrophages also occurs in the injured spinal
cord of MK2 null mice. The latter is of relevance because phos-
phorylation by MK2 stabilizes tristetraprolin, a mRNA AU-rich-
element-binding protein, which regulates TNF mRNA stability
and translation (Ronkina et al., 2010). The expression of TNF is
reduced in MK2 null mice and we have shown a 26-fold reduc-
tion of TNF at the protein level in the injured spinal cord of
MK2 null mice (Ghasemlou et al., 2010). Our results therefore
suggest that the increase in TNF expression in the injured spinal
cord regulated by MK2 plays an important role in the prolonged
maintenance of proinflammatory M1 polarization by overriding
the normal phagocytosis-induced shift to the M2 state.
Another important finding from this study is that increased
intracellular iron in macrophages promotes TNF expression in
the injured spinal cord. Iron accumulation in macrophages oc-
curs in the spinal cord after contusion injury (Rathore et al.,
2008). This iron is probably obtained from two sources: heme
iron from phagocytosed RBCs, and nonheme iron released
from damaged or dying cells. Macrophages can either recycle
the iron or sequester it leading to iron accumulation. Unlike mac-
rophages in the injured spinal cord and injured CNS, which
sequester iron from RBCs for prolonged periods (Rathore
et al., 2008), macrophages in the spleen and reticuloendothelial
system that phagocytose senescent RBCs rapidly recycle the
iron into the circulation (Donovan et al., 2006). For accumulation
to occur, the iron exporter ferroportin (Fpn) needs to be removed
from the cell membrane, which requires hepcidin-mediated1112 Neuron 83, 1098–1116, September 3, 2014 ª2014 Elsevier Inc.internalization of Fpn and its degradation (Nemeth and Ganz,
2009). We have shown previously that hepcidin is expressed
rapidly in the spinal cord after injury and is associated with loss
of Fpn that may underlie the iron accumulation after SCI (Rathore
et al., 2008).We used ferritin immunofluorescence as a surrogate
marker for intracellular iron. Ferritin expression is regulated by
intracellular iron levels via binding of iron regulatory proteins
(IRP) to iron regulatory elements (IPE) in the 50 untranslated re-
gion of ferritin mRNA (Anderson et al., 2012). Proinflammatory
cytokines can also increase ferritin synthesis as part of a series
of changes in iron handling proteins that lead to sequestration
of iron within macrophages during systemic or chronic infections
as a bactericidal effect to deprive pathogens of iron (Anderson
et al., 2012). Using intracellular ferritin as a marker for iron,
we found that increased intracellular iron favors increased
TNF expression in vivo after SCI and the appearance of a mixed
M1/M2-polarized proinflammatory cell population. A similar type
of iron-loaded mixed M1/M2-polarized cells were also recently
seen in chronic skin ulcers that lead to impaired wound healing
(Sindrilaru et al., 2011). Iron uptake by M1 macrophages was
also shown to enhance TNF secretion in vitro (Mehta et al.,
2013), and we have reported that TNF induces iron uptake and
retention in microglia in vitro (Rathore et al., 2012).
The present studies on TNF null mice show that TNF regulates
the expression of M1 andM2markers and leads to increasedM1
polarization. Further strong evidence of the iron-TNF connection
was obtained from experiments in which treatment of SCI mice
with iron-dextran led to a 3-fold increase in expression of TNF
in the injured spinal cord detected by ELISA and to worsening
of locomotor recovery. Furthermore, transplantation into the
injured spinal cord of IL-4-polarized BMDMs loaded with iron-
dextran or RBCs showed that iron loading of M2 macrophages
increases TNF expression and a switch from M2 to M1 polariza-
tion. Previous work reported that IL-4-polarized GFP+ BMDMs
transplanted into the injured spinal cord lost their M2 marker
expression (Kigerl et al., 2009). We now show that iron-loading
these cells accelerates the loss of the M2 marker (CD206) and
increases the expression of M1 marker (CD16/32); it also in-
creases TNF expression in more than 80% of the transplanted
cells as compared to about 30%of the transplanted cells without
iron-loading. Since IL-4-treated BMDMs do not express TNF
in vitro, the expression of TNF by 30% of these cells after trans-
plantation suggests that factors in the CNS environment regulate
TNF expression in M2 cells, which is increased even further by
iron-loading. Interestingly, in vitro characterization of IL-4-polar-
ized cells loaded with iron-dextran (nonheme iron) showed a
50% reduction in the M2 marker CD206 but no changes in
expression of any of M1 markers, unlike the marked increase
in M1 and decrease in M2 marker expression in cells loaded
with RBCs (heme iron). However, after transplantation, the
iron-dextran-loaded IL-4-polarized BMDMs express TNF and in-
crease CD16/32 and decrease CD206 expression to a level
almost comparable to RBC-loaded cells, suggesting that factors
in the CNS environment in the presence of loading by either
nonheme or heme iron induce a robust switch from M2 to M1
polarization and the maintenance of M1 polarization.
The link between RBC-iron loading, TNF, and switch of
macrophage polarization from M2 to M1 was also highlighted
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stantially reduced in RBC-loaded BMDMs from TNF null mice.
M2-polarized cells are thought to be specialized for iron recy-
cling by expressing molecules involved in iron uptake and
export (Corna et al., 2010). However, our findings indicate that
iron loading of these M2 cells induces a remarkably swift
change in polarization to a proinflammatory (TNF expressing)
M1 state. This switch to a proinflammatory M1 polarization state
was also evident in the marked increase in a large number of
proinflammatory M1 chemokines and cytokines detected in
the PCR array analysis.
Thus, not only can TNF prevent the myelin phagocytosis-
mediated switch from M1 to M2; it also mediates the increased
intracellular iron (RBC)-induced change of IL-4-polarized M2
cells to M1 that can underlie the robust, prominent, and pro-
longed M1 polarization in the injured spinal cord. This combined
with the appearance of an iron-containing proinflammatory
macrophage population with a mixed M1/M2 phenotype
showing incomplete conversion to M2 may further contribute
toM1 polarization that is detrimental to recovery after SCI. These
findings can have implications for a variety of neurological disor-
ders such as multiple sclerosis, stroke, amyotrophic lateral scle-
rosis, and others in which iron deposition and neuroinflammation
occur.
EXPERIMENTAL PROCEDURES
Animals and Surgical Procedures
All surgical procedures were approved by the McGill University Animal Care
Committee and followed the guidelines of the Canadian Council on Animal
Care. For the SCI, female, 6- to 8-week-old C57BL/6 mice (Charles River),
TNF/ mice (B6.129S-Tnftm1Gkl/J (Jackson labs), or MK2/ mice were
deeply anesthetized with ketamine/xylazine/acepromazine (50:5:1 mg/kg). A
laminectomy was performed at the 11th thoracic vertebrae (T11) andmoderate
contusion injuries (force of 50 kDyn, tissue displacement 400–600 mm) made
using the Infinite Horizon Impactor (Precision Scientific Instrumentation) (Gha-
semlou et al., 2005). Where indicated, 5 mg of iron-dextran at 200 ml/ mouse or
200 ml PBS-dextran (control) was injected intraperitoneally daily beginning
1 day before SCI surgery for 7 days after SCI, as described previously for in vivo
iron loading (Sindrilaru et al., 2011). Methods for locomotor assessment are
provided in the Supplemental Experimental Procedures.
Cell-Culture Experiments
Bone Marrow-Derived Macrophages
BMDMs were generated as previously described (Longbrake et al., 2007) from
adult female C57/BL6- or GFP-expressing mice (C57BL/6-Tg (UBC-GFP)
30Scha/J, Jackson Labs). Mice were euthanized and their femurs were
removed. Bone marrow was flushed out and homogenized and RBCs were
hypotonically lysed. After washing, cells were cultured in RPMI media contain-
ing 10% fetal bovine serum (FBS), 10% L-cell-conditioned media (LCCM),
a source of M-CSF, 1% penicillin/streptomycin, and 1% vitamins for 7 to
10 days until cells matured into adherent macrophages.
Microglia Cultures
Mouse microglial cultures were prepared as described previously (Saura
et al., 2003). Briefly, the neonatal mouse cerebral cortex was dissociated
and plated in tissue-culture flasks. Ten days later the confluent glial mixed
cultures were treated with mild trypsinization (0.05% trypsin with 0.25 mM
EDTA) for 5 min that detaches a layer of loosely adherent cells, which are
mainly astrocytes, and leaves behind firmly adherent cells, which are >
90% microglia (see FACS in Figure 2). Afterward, cells were cultured for
5 days in DMEM/F12 culture medium containing 10% FBS, 1% penicillin/
streptomycin, and 1% vitamins mixed 1:1 with mixed glial cell-conditioned
media before stimulation.NeStimulation of Macrophages and Microglia In Vitro
BMDM and microglia cultures were stimulated with LPS (100 ng/ml) or LPS+
IFN-g (20 ng/ml) as previously described (Kigerl et al., 2009) for 24 hr followed
by thorough washing and incubation with bovine CNS myelin (50 mg/ml)
for 16 hr. Where indicated, rTNF (25ng/ml) was added to LPS and myelin incu-
bation steps. After stimulation, cells were used for flow cytometry or the
conditioned medium was obtained for cytotoxicity assays and DRG cultures.
Supernatants were filtered using 0.22 mm pore sized filters to remove LPS
as previously described (Gensel et al., 2009). Alternatively, BMDMs were
treated with IL-4 (20 ng/ml) with or without iron-dextran (20 mM) or RBCs (at
a concentration of 10:1) overnight and used for transplantation into the spinal
cord, qPCR, and gene expression array or cells were rigorously washed, incu-
bated in serum-containing media for 3 days, and used for qPCR analysis. All
reagents were obtained from Sigma-Aldrich. RBCs were artificially aged to
enhance phagocytosis by macrophages (Delaby et al., 2005). Briefly, blood
was collected from adult C57BL/6 mice in EDTA precoated tubes, washed
with PBS, centrifuged, and resuspended in HEPES buffer containing calcium
(2.5 mM) and the Ca2+ ionophore A23187 (0.5 mM; Streptomyces chartreusis;
Sigma). RBCs were incubated at 30

C overnight, washed twice in PBS, and
incubated with BMDMs at a ratio of 10:1.
Methods for Transplantation of GFP+ BMDMs are provided in the Supple-
mental Experimental Procedures.
Flow Cytometry
At 1, 4, or 15 days after contusion injury, micewere transcardially perfusedwith
phosphate-buffered saline (PBS) and a 5 mm section of the spinal cord con-
taining the lesion site was dissected. Mice with laminectomy alone served
as controls. Cells were extracted as previously described (Berard et al.,
2010). FACS staining was performed following standard protocols for tissue-
derived cells or cultured BMDMs or microglia. Before intracellular cytokine
staining, cells were incubated with brefeldin (1:1000, Biolegend) to enhance
the signal (Jung et al., 1993). Nonspecific antibody binding was blocked by
incubation with 5% bovine serum albumin (BSA). The full list of the different
antibodies used is provided in the Supplemental Experimental Procedures.
Compensation was performed using a compensation particles set (BD Biosci-
ences). Neutrophils that are present early after spinal cord injury were
excluded from the analysis on day 1 on the basis of their high granularity. Cells
were analyzed using a FACS CantoII flow cytometer with FACS Diva software.
Results were analyzed using FlowJo software.
Histological Analysis
At 7 or 14 days after contusion injury or 3 days after transplantation of GFP+
BMDMs, mice were perfused with 4% paraformaldehyde in 0.1M phosphate
buffer (PB). A 5 mm length of the spinal cord containing the lesion site was
dissected and cryoprotected with 30% sucrose in 0.1M PB, and serial cryostat
sections (14mm thick)were obtained. The full list of antibodies used for immuno-
fluorescencestaining isprovided in theSupplementalExperimental Procedures.
Tissue sections were viewed with a Zeiss Axioskop 2 Plus microscope and im-
ages captured using a QImaging Retiga 1300 camera, or a confocal laser scan-
ning microscope (FluoView FV1000, Olympus) with FV10-ASW 3.0 software
(Olympus). Quantification was done using ImageJ software. All individual cell
countswerecarriedoutondigital images taken200mmfromthe lesionepicenter.
Iron was detected using the diaminobenzidine (DAB) enhanced Turnbull
blue iron staining as follows: tissue sections were incubated in 10% ammo-
nium sulfide solution for 90 min, followed by incubation in 20% potassium-
ferricyanide with 1% HCl for 15 min, methanol with 0.01M NaN3 and 0.3%
H2O2 for 60 min, and 0.025% DAB with 0.005% H2O2 for 20 min. Sections
were washed between incubations, the DAB reaction was stopped with water.
Methods for DHE and TUNEL staining are provided in the Supplemental Exper-
imental Procedures.
ELISA
At day 5 after SCI, iron-dextran- and dextran-treated control mice were trans-
cardially perfused with ice-cold PBS and a 5 mm section of the spinal cord
containing the lesion site was dissected and snap frozen. Protein was ex-
tracted and TNF measured using a TNF ELISA kit (R&D Systems) following
manufacturer instructions.uron 83, 1098–1116, September 3, 2014 ª2014 Elsevier Inc. 1113
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Statistical tests were performed using Graphpad Prisms 5 software. Statistical
analyses were performed by using Student’s t test or Mann-Whitney-U test or
two-way repeated-measures ANOVA (RM-ANOVA) with post hoc Bonferroni
test for multiple comparisons. Differences were considered significant at
p < 0.05.
See Supplemental Experimental Procedures for additional information on
methods.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2014.07.027.
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